Neuraxpharm Email Format

Pharmaceutical ManufacturingCatalonia, Spain501-1000 Employees

Neuraxpharm is a European specialty pharmaceutical company that concentrates on therapies for the central nervous system, covering both psychiatric and neurological conditions. Its activities encompass the development and commercialization of CNS products, with growth driven by an active pipeline, partnerships, and acquisitions. The company maintains a direct presence in more than 20 European markets, with additional reach in two Latin American countries, one in the Middle East, and one in Australia, and it collaborates with partners in more than 50 countries globally. Much of its manufacturing occurs at Neuraxpharm Pharmaceuticals in Spain, a facility that originated as Laboratorios Lesvi. The workforce is on the order of about a thousand employees. In late 2025, Neuraxpharm announced EPISERAS, a digital health solution that leverages an AI-powered wearable to aid early detection of epileptic seizures.

Sign up for free to view info

Company overview Employee directory